The role of osteopontin in inflammatory processes expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 56(6):1662–1670 Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA (1999) Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 67 (8):4223–4230 Nishimichi N, Higashikawa F, Kinoh HH, Tateishi Y, Matsuda H, Yokosaki Y (2009) Polymeric osteopontin employs integrin alpha 9beta 1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem 284:14769–14776 Nystrom T, Duner P, Hultgardh-Nilsson A (2007) A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 313(6):1149–1160 O’Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterios- cler Thromb 14(10):1648–1656 Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, Towler DA, Law RE, Hsueh WA, Bruemmer D (2005) Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res 96(7):e59–67 Ohri R, Tung E, Rajachar R, Giachelli CM (2005) Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin. Calcif Tissue Int 76(4):307–315 Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita- Sasai M, Kobayashi H, Shimizu M, Katada Y, Wakitani S, Murata N, Nomura S, Matsuno H, Katayama R, Kon S, Inobe M, Uede T, Kawase I, Saeki Y (2002) Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 29(10):2061–2067 Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56 (2):571–580 O’Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS (1999) Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 162(2):1024–1031 O’Regan AW, Hayden JM, Berman JS (2000) Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 68(4):495–502 Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, Mukherjee BB, Li XD, Mukherjee DC, Seides S, Rosenberg J, Stark K, Mukherjee AB (1997) Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 94 (17):9308–9313 Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking R, Wolf G, Helmchen U, Stahl R (2001) Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59 (5):1762–1769 Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, Blattner F, Regnier DC, Kozak CA, Mock BA, Morse HC 3rd, Jerrells TR, Cantor H (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170(1):145–161 Patarca R, Saavedra R, Cantor H (1993) Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T- lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13 (3–4):225–246 321 Persy V, Verhulst A, Ysebaert D, De Greef K, De Broe M (2003) Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63(2):543–553 Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T, Martin SF, Simon JC, Weiss JM (2005) Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1- polarizing phenotype. Blood 106(3):946–955 Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13(7):1101–1111 Rollo EE, Laskin DL, Denhardt DT (1996) Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukoc Biol 60(3):397–404 Schulz G, Renkl AC, Seier A, Liaw L, Weiss JM (2008) Regulated osteopontin expression by dendritic cells decisively affects their migratory capacity. J Invest Dermatol 128(10):2541–2544 Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5(5):565–574 Senger DR, Perruzzi CA (1996) Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim Biophys Acta 1314(1–2):13–24 Senger DR, Perruzzi CA, Papadopoulos A (1989) Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9(5):1291–1299 Sennels H, Sorensen S, Ostergaard M, Knudsen L, Hansen M, Skjodt H, Peters N, Colic A, Grau K, Jacobsen S (2008) Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with metho- trexate. Scand J Rheumatol 37(4):241–247 Shinohara ML, Jansson M, Hwang ES, Werneck MB, Glimcher LH, Cantor H (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A 102(47):17101–17106 Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH, Cantor H (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7(5):498–506 Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (2008a) Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci U S A 105(20):7235– 7239 Shinohara ML, Kim JH, Garcia VA, Cantor H (2008b) Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29(1):68–78 Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A (2008) Macrophage polariza- tion in tumour progression. Semin Cancer Biol 18(5):349–55 Singh K, DeVouge MW, Mukherjee BB (1990) Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 265(30):18696–18701 Smith LL, Giachelli CM (1998) Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. Exp Cell Res 242(1):351–360 Smith LL, Cheung HK, Ling LE, Chen J, Sheppard D, Pytela R, Giachelli CM (1996) Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem 271(45):28485–28491